Meeting HHS’ minimum requirements for daily and weekly exercise reduced breast cancer recurrence and mortality among patients with high-risk breast cancer undergoing chemotherapy. This benefit was even seen in patients who had not met these requirements before their diagnosis.
Even meeting HHS’s minimum requirements for daily and weekly exercise reduced breast cancer recurrence and mortality among patients with high-risk disease undergoing chemotherapy. This benefit was even seen in patients who had not met these requirements before their diagnosis, according to research from Roswell Park Comprehensive Cancer Center in Buffalo, New York, published in Journal of the National Cancer Institute.
The patient population they investigated consisted of 1340 individuals currently enrolled in the Diet, Exercise, Lifestyles and Cancer Prognosis (DELCaP) study, a questionnaire distributed as part of a larger trial from SWOG. Their levels of physical activity, according to HHS’ Physical Activity Guidelines for Americans, and the resulting effects were measured at 4 time points:
Four levels of physical activity were also used to classify patients, according to weekly MET hours:
Overall, large reductions in disease recurrence and mortality were seen among the patients who met the RPA guidelines both before and in the year following enrollment. These hazard ratios (HRs) were 0.59 (95% CI, 0.42-0.82) and 0.51 (95% CI, 0.34-0.77), respectively. These numbers only got better at the 2-year mark, coming in at 0.45 (95% CI, 0.31-0.65) and 0.32 (95% CI, 0.19-0.52).
When looking at amounts of RPA each week, the patients classified as low active (HR, 0.41; 95% CI, 0.24-0.68), moderate active (HR, 0.42; 95% CI, 0.23-0.76), and high active (HR, 0.31; 95% CI, 0.18-0.53) saw the most gains in mortality improvement.
Overall, the most patients (75.1%) were active at the 2-year mark. In addition, any level of consistent RPA throughout the study translated to 19% and 22% drops in disease recurrence and mortality, respectively. Even larger statistically significant gains were seen following time-dependent analyses. The mortality rate fell by 63% among patients who exercised on a regular basis versus those who did not and by 60% if they met the minimum requirements for RPA.
“Taken collectively, these findings have important implications in the clinical oncology setting because they suggest that a cancer diagnosis may serve as an impetus for increasing physical activity in some patients, and among these patients, beginning an exercise program after treatment resulted in a survival advantage,” stated Rikki Cannioto, PhD, ED, assistant professor of oncology, Department of Cancer Prevention and Control, Roswell. “These observations coincide with previous findings from our group showing that lower levels of regular, weekly activity were associated with a significant survival advantage.”
Due to the self-reported nature of the study, the study authors express caution about the possibility of recall errors on the part of the patients, which could mean data misclassification and skewed results.
Reference
Cannioto RA, Hutson A, Dighe S, et al. Physical activity before, during and after chemotherapy for high-risk breast cancer: relationships with survival [published online April 2, 2020]. J Natl Cancer Inst. doi: 10.1093/jnci/djaa046.
Metabolic Syndrome, Obesity Contribute to Breast Cancer Mortality in Postmenopausal Women
May 13th 2024A large study finds that obesity and metabolic syndrome raise breast cancer mortality risk, but through different mechanisms. Metabolic syndrome is linked to a specific type of breast cancer, whereas obesity increases risk across all breast cancer subtypes.
Read More
Emily Goldberg Shares Insights as a Genetic Counselor for Breast Cancer Risk Screening
October 30th 2023On this episode of Managed Care Cast, Emily Goldberg, MS, CGC, a genetic counselor at JScreen, breaks down how genetic screening for breast cancer works and why it is so important to increase awareness and education around these screening tools available to patients who may be at risk for cancer.
Listen
Social Equity, Strong Health Care Systems Can Improve Advanced Breast Cancer Outcomes Globally
May 6th 2024Disparities in health care systems around the world limit access to effective treatments for advanced breast cancer, especially for people in low- and middle-income countries and marginalized communities. Stronger health systems and social education efforts are necessary to improve outcomes for all patients.
Read More
The Disproportionate Impact of the Pandemic on Health Care Disparities and Cancer
February 22nd 2022On this episode of Managed Care Cast, we discuss how already wide health care inequities in cancer are becoming much worse because of the COVID-19 pandemic, with guest Monica Soni, MD, associate chief medical officer at New Century Health.
Listen
USPSTF Lowers Age for Biennial Mammograms to 40, Citing Early Detection Benefit
April 30th 2024The USPSTF lowered the recommended starting age for mammograms from 50 to 40 years, citing moderate benefits for early detection in this age group. Disparities persist, especially for Black women, highlighting the need for improved access to health care and social support.
Read More